Congress:
ECR25
Poster Number:
C-27307
Type:
Poster: EPOS Radiologist (scientific)
DOI:
10.26044/ecr2025/C-27307
Authorblock:
R. Vliegenthart1, G. Sidorenkov1, M. Prokop2, H. Groen1, P. De Jong3, C. Jacobs1, F. A. A. Mohamed Hoesein3, R. Stadhouders4, G. De Bock1; 1Groningen/NL, 2Nijmegen/NL, 3Utrecht/NL, 4Rotterdam/NL
Disclosures:
Rozemarijn Vliegenthart:
Grant Recipient: Institutional research grants, Siemens Healthineers Speaker: Siemens Healthineers, Bayer Healthcare
Grigory Sidorenkov:
Nothing to disclose
Mathias Prokop:
Other: royalties to institution from MeVis medical solutions Speaker: Siemens Healthineers, Bayer, Bracco, Canon Medical Systems
Harry Groen:
Nothing to disclose
Pim De Jong:
Research/Grant Support: Institutional support, Philips healthcare
Colin Jacobs:
Speaker: Canon medical systems, Johnson&Johnson Research/Grant Support: MeVis medical solutions, Philips medical systems Other: Royalties to institution from MeVis medical solutions
Firdaus A. A. Mohamed Hoesein:
Nothing to disclose
Ralph Stadhouders:
Nothing to disclose
Geertruida De Bock:
Nothing to disclose
Keywords:
Artificial Intelligence, Lung, CT, Outcomes analysis, Screening, Arteriosclerosis, Cancer, Chronic obstructive airways disease
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020;382:503-513. doi: 10.1056/NEJMoa1911793. PMID: 31995683
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial. Radiology. 2024;313:e240535. doi: 10.1148/radiol.240535.PMID: 39436294
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial. Eur J Epidemiol. 2023;38:445-454. doi: 10.1007/s10654-023-00975-9.